Diagnostyka (DIA) Stock Overview
Provides diagnostic services in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
DIA Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Diagnostyka S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł172.50 |
| 52 Week High | zł219.90 |
| 52 Week Low | zł146.40 |
| Beta | 0 |
| 1 Month Change | 7.08% |
| 3 Month Change | 2.53% |
| 1 Year Change | 5.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 32.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| DIA | PL Healthcare | PL Market | |
|---|---|---|---|
| 7D | -1.1% | -0.5% | -0.5% |
| 1Y | 5.2% | 3.2% | 30.8% |
Return vs Industry: DIA exceeded the Polish Healthcare industry which returned 3.2% over the past year.
Return vs Market: DIA underperformed the Polish Market which returned 30.8% over the past year.
Price Volatility
| DIA volatility | |
|---|---|
| DIA Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 4.9% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PL Market | 10.5% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: DIA has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: DIA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 8,645 | Jakub Swadzba | www.diag.pl |
Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests.
Diagnostyka S.A. Fundamentals Summary
| DIA fundamental statistics | |
|---|---|
| Market cap | zł5.83b |
| Earnings (TTM) | zł261.30m |
| Revenue (TTM) | zł2.51b |
Is DIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DIA income statement (TTM) | |
|---|---|
| Revenue | zł2.51b |
| Cost of Revenue | zł520.70m |
| Gross Profit | zł1.99b |
| Other Expenses | zł1.73b |
| Earnings | zł261.30m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Sep 10, 2026
| Earnings per share (EPS) | 7.74 |
| Gross Margin | 79.26% |
| Net Profit Margin | 10.41% |
| Debt/Equity Ratio | 101.0% |
How did DIA perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/23 17:47 |
| End of Day Share Price | 2026/06/23 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Diagnostyka S.A. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Beata Szparaga-Wasniewska | Biuro maklerskie mBanku |
| Giang Nguyen | Citigroup Inc |
| Tomasz Sokolowski | Erste Bank Polska S.A. |